How REYATAZ Can Help
REYATAZ is an HIV medication available by prescription. It is used in combination with other medicines to treat people 6 years of age and older who are infected with the human immunodeficiency virus (HIV). REYATAZ has been studied in a 48-week trial in patients who have taken anti-HIV medicines and a 96-week trial in patients who have never taken anti-HIV medicines.
REYATAZ does not cure HIV or lower your chance of passing HIV to others. People taking REYATAZ may still get opportunistic infections or other conditions that happen with HIV infection.
REYATAZ is in a class of HIV medications called protease inhibitors (PIs). Protease inhibitors are a kind of HIV medication that fights HIV by preventing the virus from multiplying.
Do not take REYATAZ if you are allergic to REYATAZ or to any of its ingredients.
Read more REYATAZ Important Safety Information.
Once-daily REYATAZ, as part of HIV combination therapy, has been demonstrated effective in managing HIV. REYATAZ® (atazanavir sulfate) is an HIV medication that:
- Is taken once a day with a snack or meal. Swallow the capsules whole; do not open the capsules. You should take REYATAZ and your other anti-HIV medicines exactly as instructed by your healthcare provider.
- Can help lower your viral load to undetectable levels*. That means REYATAZ can lower the amount of HIV in your blood until it cannot be measured by current tests.
- Can help raise your CD4+ cell (or T-cell) count. CD4+ cells are an important part of your immune system. The more CD4+ cells you have, the stronger your immune system.
- Has a low chance of diarrhea in adults (a 1-3% rate of moderate-to-severe diarrhea in clinical trials).
Selected Important Safety Information
About REYATAZ® (atazanavir sulfate)
Do not take REYATAZ if you are taking the following medicines due to potential for serious, life-threatening side effects or death: Versed® (midazolam) when taken by mouth, Halcion® (triazolam), ergot medicines (dihydroergotamine, ergonovine, ergotamine, and methylergonovine such as Cafergot®, Migranal®, D.H.E. 45®, ergotrate maleate, Methergine®, and others), Propulsid® (cisapride), or Orap® (pimozide).
Do not take REYATAZ with the following medicines due to potential for serious side effects: Camptosar® (irinotecan), Crixivan® (indinavir), Mevacor® (lovastatin), Zocor® (simvastatin), Uroxatral® (alfuzosin), or Revatio® (sildenafil).
Do not take REYATAZ with the following medicines as they may lower the amount of REYATAZ in your blood, which may lead to increased HIV viral load and resistance to REYATAZ or other anti-HIV medicines: rifampin (also known as Rimactane®, Rifadin®, Rifater®, or Rifamate®), St. John’s wort (Hypericum perforatum)-containing products, or Viramune® (nevirapine).
Serevent Diskus® (salmeterol) and Advair® (salmeterol with fluticasone) are not recommended with REYATAZ.
Do not take Vfend® (voriconazole) if you are taking REYATAZ and Norvir® (ritonavir).
The above lists of medicines are not complete. Taking REYATAZ with some other medicines may require your therapy to be monitored more closely or may require a change in dose or dose schedule of REYATAZ or the other medicine. Discuss with your healthcare provider all prescription and non-prescription medicines, vitamin and herbal supplements, or other health preparations you are taking or plan to take.
Read more REYATAZ Important Safety Information.
*"Undetectable" is defined as a viral load that is too low to be picked up by a particular test. Typically, it is a viral load of less than 400 or 50 copies/mL (depending on the test used).